Page 44 - 南京医科大学学报自然科学版
P. 44

第42卷第7期
               ·940 ·                            南 京    医 科 大 学 学         报                        2022年7月


              产生直接影响 PI3K/Akt 通路降低 HIF1α表达,未来                        AKT/HIF⁃1α/HK2 axis of breast cancer cells:combined
              将进一步研究 ALCAT1⁃ROS⁃HIF1α轴背后的分子                          administration of polydatin and 2⁃deoxy⁃d⁃glucose[J]. J
              事件以及与线粒体呼吸和线粒体功能联系,并将                                  Cell Mol Med,2019,23(5):3711-3723
              在更多的癌症模型中去验证 ALCAT1 缺失对肿瘤                         [11] WEINBERG F,HAMANAKA R,WHEATON W W,et al.
                                                                     Mitochondrial metabolism and ROS generation are essen⁃
              发生发展的影响。
                                                                     tial for Kras ⁃ mediated tumorigenicity[J]. PNAS,2010,
                  综上所述,ALCAT1 的缺失减缓 KRAS 突变导
                                                                     107(19):8788-8793
              致的肺腺癌的发展,在 KRAS 突变的人肺腺癌细胞
                                                                [12] PARADIES G,PARADIES V,RUGGIERO F M,et al. Mi⁃
              中药理学抑制 ALCAT1 可能通过阻止 ROS 的产生
                                                                     tochondrial bioenergetics and cardiolipin alterations in
              降低 HIF1α表达,从而减少糖酵解代谢产物的生                               myocardial ischemia ⁃ reperfusion injury:implications for
              成,影响 Akt 磷酸化水平。这为开发新型抗肺癌药                              pharmacological cardioprotection[J]. Am J Physiol Heart
              物提供了新的干预靶点,也为后续机制研究提供了                                 Circ Physiol,2018,315(5):H1341-H1352
              基础。                                               [13] SHILOVSKY G A,PUTYATINA T S,ASHAPKIN V V,et
                                                                     al. Biological diversity and remodeling of cardiolipin in
             [参考文献]
                                                                     oxidative stress and age⁃related pathologies[J]. Biochem
             [1] SCHABATH M B,COTE M L. Cancer progress and priori⁃  Biokhimiia,2019,84(12):1469-1483
                   ties:lung cancer[J]. Cancer Epidemiol Biomark Prev,
                                                                [14] GÜRTLER S,WOLKE C,OTTO O,et al. Tafazzin⁃depen⁃
                   2019,28(10):1563-1579                             dent cardiolipin composition in C6 glioma cells correlates
             [2] SANAEI M J,RAZI S,POURBAGHERI⁃SIGAROODI A,
                                                                     with changes in mitochondrial and cellular functions,and
                   et al. The PI3K/Akt/mTOR pathway in lung cancer;onco⁃  cellular proliferation[J]. Biochim Biophys Acta Mol Cell
                   genic alterations,therapeutic opportunities,challenges,  Biol Lipids,2019,1864(4):452-465

                   and a glance at the application of nanoparticles[J].  [15] ZHANG J L,YU W D,RYU S W,et al. Cardiolipins are
                   Transl Oncol,2022,18:101364                       biomarkers of mitochondria⁃rich thyroid oncocytic tumors
             [3] RECK M,CARBONE D P,GARASSINO M,et al. Target⁃      [J]. Cancer Res,2016,76(22):6588-6597
                   ing KRAS in non⁃small⁃cell lung cancer:recent progress  [16] SCHILD L,DÖRING M,JANSING S,et al. Proliferation
                   and new approaches[J]. Ann Oncol,2021,32(9):1101-  of C6 glioma cells requires the phospholipid remodeling
                   1110                                              enzyme tafazzin independent of cardiolipin composition
             [4] KAUKO O,O’CONNOR C M,KULESSKIY E,et al.            [J]. Biochim Biophys Acta Mol Cell Biol Lipids,2020,
                   PP2A inhibition is a druggable MEK inhibitor resistance  1865(3):158596
                   mechanism in KRAS ⁃ mutant lung cancer cells[J]. Sci  [17] LI J,ROMESTAING C,HAN X L,et al. Cardiolipin re⁃
                   Transl Med,2018,10(450):eaaq1093                  modeling by ALCAT1 links oxidative stress and mitochon⁃
             [5] HU K W,LI K,LV J,et al. Suppression of the SLC7A11/  drial dysfunction to obesity[J]. Cell Metab,2010,12(2):
                   glutathione axis causes synthetic lethality in KRAS⁃mu⁃  154-165
                   tant lung adenocarcinoma[J]. J Clin Investig,2020,130  [18] SONG C J,ZHANG J,QI S S,et al. Cardiolipin remodel⁃
                  (4):1752-1766                                      ing by ALCAT1 links mitochondrial dysfunction to Par⁃
             [6] WANG X H,JIANG Z H,YANG H M,et al. Hypoxia⁃in⁃      kinson’s diseases[J]. Aging Cell,2019,18(3):e12941
                   duced FOXO4/LDHA axis modulates gastric cancer cell  [19] JIA D D,ZHANG J,NIE J,et al. Cardiolipin remodeling
                   glycolysis and progression[J]. Clin Transl Med,2021,11  by ALCAT1 links hypoxia to coronary artery disease by
                  (1):e279                                           promoting mitochondrial dysfunction[J]. Mol Ther,2021,
             [7] MAGAWAY C,KIM E,JACINTO E. Targeting mTOR           29(12):3498-3511
                   and metabolism in cancer:lessons and innovations[J].  [20] HUANG L S,KOTHA S R,AVASARALA S,et al. Lyso⁃
                   Cells,2019,8(12):1584                             cardiolipin acyltransferase regulates NSCLC cell prolifera⁃
             [8] HAM P B,RAJU R. Mitochondrial function in hypoxic   tion and migration by modulating mitochondrial dynamics
                   ischemic injury and influence of aging[J]. Prog Neurobi⁃  [J]. J Biol Chem,2020,295(38):13393-13406
                   ol,2017,157:92-116                           [21] KONSTANTINIDOU G,RAMADORI G,TORTI F,et al.
             [9] MORO L. Mitochondrial dysfunction in aging and cancer  RHOA⁃FAK is a required signaling axis for the mainte⁃
                  [J]. J Clin Med,2019,8(11):1983                    nance of KRAS⁃driven lung adenocarcinomas[J]. Cancer
             [10] ZHANG T,ZHU X,WU H,et al. Targeting the ROS/PI3K/                             (下转第972页)
   39   40   41   42   43   44   45   46   47   48   49